Pazdur, Marks and Woodcock Discuss FDA Changes, What’s Coming
June 18, 2019 Center for Drug Evaluation and Research (CDER) Director Woodcock said that the difference between years past, when FDA was viewed negatively, and now is that there has been a sort of scientific revolution, with biology being harnessed in novel ways and investments at NIH paying off. Oncology Center of Excellence Director Pazdur … Read more